This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2002 Oct;288(16):2042-3.

doi: 10.1001/jama.288.16.2042.

Homocysteine and coronary heart disease: how great is the hazard?

Peter W F Wilson

PMID: 12387658
DOI: 10.1001/jama.288.16.2042

Editorial

Homocysteine and coronary heart disease: how great is the hazard?

Peter W F Wilson. JAMA. 2002 Oct.

. 2002 Oct;288(16):2042-3.

doi: 10.1001/jama.288.16.2042.

Author

Peter W F Wilson

PMID: 12387658
DOI: 10.1001/jama.288.16.2042

No abstract available

PubMed Disclaimer

Comment on

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.
Homocysteine Studies Collaboration. Homocysteine Studies Collaboration. JAMA. 2002 Oct 23-30;288(16):2015-22. doi: 10.1001/jama.288.16.2015. JAMA. 2002. PMID: 12387654
MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.
Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group. Klerk M, et al. JAMA. 2002 Oct 23-30;288(16):2023-31. doi: 10.1001/jama.288.16.2023. JAMA. 2002. PMID: 12387655

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems